Holen Sie sich die Stockscreener-App
78.79
7.61%
5.57
Schlusskurs vom Vortag:
$73.22
Offen:
$75.26
24-Stunden-Volumen:
1.79M
Relative Volume:
1.37
Marktkapitalisierung:
$2.72B
Einnahmen:
$635.89M
Nettoeinkommen (Verlust:
$171.92M
KGV:
18.08
EPS:
4.357
Netto-Cashflow:
$151.36M
1W Leistung:
+7.07%
1M Leistung:
+15.29%
6M Leistung:
-34.92%
1J Leistung:
-36.46%
1-Tages-Spanne:
$75.12
$80.72
1-Wochen-Bereich:
$71.33
$80.72
52-Wochen-Spanne:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
78.79 | 2.72B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Hochstufung | Needham | Hold → Buy |
| 2025-10-13 | Eingeleitet | Jefferies | Buy |
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
Virtu Financial LLC Buys 22,202 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Lost Money on TransMedics Group, Inc.(TMDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The National Law Review
TMDX Maintained by Stifel -- Price Target Raised to $80.00 - GuruFocus
TransMedics Group Jumps 6.6% Amid Sector-Wide Rally - AlphaStreet
Stifel raises TransMedics stock price target on strong flight data - Investing.com UK
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $80.00 - MarketBeat
Why (TMDX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
TransMedics (TMDX) director exercises 19,285 options and sells shares - Stock Titan
Transmedics Group Inc (TMDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Transmedics Group Inc (TMDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Transmedics Group Inc (TMDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Transmedics Group Inc (TMDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Transmedics Group Inc (TMDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Transmedics Group Inc (TMDX) Institutional Confidence - TradingKey
Transmedics Group Inc (TMDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Transmedics Group Inc (TMDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Transmedics Group Inc (TMDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
[144] TransMedics Group, Inc. SEC Filing - Stock Titan
Q1 2026 Transmedics Group Inc Earnings Call Transcript - GuruFocus
TMDX News | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
Law firm investigates TransMedics after margin pressure and investment disclosures hurt stock price - Pluang
Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning ... - Enidnews.com
Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
TransMedics Group Jumps 5.8% Amid Sector-Wide Rally - AlphaStreet
TransMedics: Why I'm Still Bullish After The Collapse (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. Trade Ideas — XETR:8T8 - TradingView
Price to book ratio of TransMedics Group, Inc. – XETR:8T8 - TradingView
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative? - Yahoo Finance
TransMedics faces earnings test as jet fuel costs weigh By Investing.com - Investing.com Australia
TransMedics Group Inc Stock Operating Data - GuruFocus
Oppenheimer downgrades TransMedics stock rating on sentiment concerns - Investing.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - AOL.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals - ChartMill
Earnings call transcript: TransMedics Q1 2026 misses EPS forecast, stock stable - Investing.com Australia
TransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Oppenheimer downgrades TransMedics stock rating on sentiment concerns By Investing.com - Investing.com UK
TMDX: Revolutionizing organ transplantation with record utilization rates and ambitious global growth targets - TradingView
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Hold" by Brokerages - MarketBeat
TransMedics Group, Inc. (TMDX) Stock Analysis: A 73.78% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Reasons to retain TransMedics stock in your portfolio for now - MSN
What Drove TransMedics' Stellar Q4 2025 Performance - Kavout
Is TransMedics Group Inc (TMDX) a Bargain After 3.3% Drop? GF Va - GuruFocus
Reasons to Retain TransMedics Stock in Your Portfolio for Now - Yahoo Finance
Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ - MSN
Avoiding Lag: Real-Time Signals in (TMDX) Movement - Stock Traders Daily
TMDX Maintained by Stifel -- Price Target Lowered to $75.00 - GuruFocus
TransMedics Group Inc (TMDX) Stock Price, Trades & News - GuruFocus
Stifel Nicolaus Lowers TransMedics Group (NASDAQ:TMDX) Price Target to $75.00 - MarketBeat
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Transmedics Group Inc-Aktie (TMDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):